These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 10225463)

  • 1. Prognostic aspects of TcPO2 in iloprost treatment as an alternative to amputation.
    Chomard D; Habault P; Ledemeney M; Haon C
    Angiology; 1999 Apr; 50(4):283-8. PubMed ID: 10225463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostacyclin (iloprost) as an adjuvant in local surgical therapy of stage IV arterial occlusive disease--is quantification of the therapeutic effect possible with tcPO2 measurements?].
    Breuer C; Abri O
    Vasa; 1995; 24(1):62-71. PubMed ID: 7536999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criteria predictive of limb viability at 1 year in patients with chronic severe ischemia--TcPO2 and demographic parameters.
    Chomard D; Habault P; Eveno D; Le Lamer S; Ledemeney M; Haon C
    Angiology; 2000 Sep; 51(9):765-76. PubMed ID: 10999618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of transcutaneous oxygen pressure and amputation success by use of supine and elevation measurements.
    Bacharach JM; Rooke TW; Osmundson PJ; Gloviczki P
    J Vasc Surg; 1992 Mar; 15(3):558-63. PubMed ID: 1538514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative analysis of transcutaneous oximetry (tcPO2) during oxygen inhalation and leg dependency in severe peripheral arterial occlusive disease.
    Scheffler A; Rieger H
    J Vasc Surg; 1992 Aug; 16(2):218-24. PubMed ID: 1495145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive arterial studies including transcutaneous oxygen pressure measurements with the limbs elevated or dependent to predict healing after partial foot amputation.
    Andrews KL; Dib MY; Shives TC; Hoskin TL; Liedl DA; Boon AJ
    Am J Phys Med Rehabil; 2013 May; 92(5):385-92. PubMed ID: 23478457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcutaneous oxygen and carbon dioxide levels with iloprost administration in diabetic critical limb ischemia.
    Melillo E; Ferrari M; Balbarini A; Pedrinelli R
    Vasc Endovascular Surg; 2006; 40(4):303-11. PubMed ID: 16959724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance of Iloprost and results of treatment of chronic severe lower limb ischaemia in diabetic patients. A retrospective study of 64 consecutive cases.
    Duthois S; Cailleux N; Benosman B; Lévesque H
    Diabetes Metab; 2003 Feb; 29(1):36-43. PubMed ID: 12629446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of non-reconstructable lower critical limb ischemia?
    Melillo E; Nuti M; Pedrinelli R; Buttitta F; Balbarini A
    Minerva Cardioangiol; 2006 Aug; 54(4):481-98. PubMed ID: 17016419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of transcutaneous oxymetry in vascular surgery.
    Szala K; Kostewicz W; Noszczyk W
    Int Angiol; 1988; 7(4):301-4. PubMed ID: 3243984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Follow-up study, using dynamic transcutaneous oximetry in 17 patients with stage II Leriche and Fontaine occlusive arterial disease of the lower limbs].
    Grard C; Perez-Cousin M; Desmyttère J; Alsberghe MC; Hachulla E; Copin D; Roux JP; Brouillard M; Hatron PY; Warembourg H
    Rev Med Interne; 1994; 15(8):510-4. PubMed ID: 7938965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival of patients with critical limb ischemia treated with iloprost: response rate and predictive criteria. A retrospective analysis of 102 patients.
    Melillo E; Lucaccini E; Berchiolli R; Adami D; Nuti M; Dell'Omo G; Farina A; Panigada G; Roberts AT; Meini S
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5233-5241. PubMed ID: 28051243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting amputation in severe ischaemia. The value of transcutaneous PO2 measurement.
    Bongard O; Krähenbühl B
    J Bone Joint Surg Br; 1988 May; 70(3):465-7. PubMed ID: 3372572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of transcutaneous oxygen tension (TcPO2) measurement in the testing period of spinal cord stimulation in diabetic patients with critical lower limb ischaemia.
    Petrakis E; Sciacca V
    Int Angiol; 2000 Mar; 19(1):18-25. PubMed ID: 10853681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical information content of transcutaneous oxymetry (tcpO2) in peripheral arterial occlusive disease (a review of the methodological and clinical literature with a special reference to critical limb ischaemia).
    Scheffler A; Rieger H
    Vasa; 1992; 21(2):111-26. PubMed ID: 1621428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transcutaneous oxygen pressure (TcPO2): advantages and limitations].
    Got I
    Diabetes Metab; 1998 Sep; 24(4):379-84. PubMed ID: 9805653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous oxygen tension (TcPO2) in the testing period of spinal cord stimulation (SCS) in critical limb ischemia of the lower extremities.
    Petrakis IE; Sciacca V
    Int Surg; 1999; 84(2):122-8. PubMed ID: 10408282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
    Duthois S; Cailleux N; Lévesque H
    J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical therapy in critical lower limb ischemia when immediate revascularization is not feasible].
    Melillo E; Nuti M; Buttitta F; Balbarini A
    G Ital Cardiol (Rome); 2006 May; 7(5):317-35. PubMed ID: 16752515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resting TcPO2 levels decrease during liner wear in persons with a transtibial amputation.
    Berli MC; Jundt-Ecker M; Meier MR; Hofer M; Schöni M; Götschi T; Uçkay I; Böni T; Waibel FWA
    PLoS One; 2020; 15(9):e0239930. PubMed ID: 32986780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.